RxDoctor Payments Data

Kathleen Scott

Neurology · Dallas, TXNPI 1023269495

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,906 of the $9,957 with a category attached, or 89.4%. It is spread thinly across 57 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,246 and has fallen 84.9% since, to $339 in 2025.

$9,957in general payments, 2019–2025

Across 476 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Livanova USA, Inc.$1K
  • Novartis$593
  • Amgen$467
  • Avanir Pharmaceuticals, Inc.$377
  • UCB, Inc.$356
  • plus $5K from 51 others

What the payments were for

  • Speaking & faculty fees$180%
  • Travel & lodging$1,03310%
  • Food & beverage$8,90689%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,957 in reported general payments places this provider in the 70th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Other neurology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →